Irit Gil‐Ad

4.0k citations

105 papers · 3.1k indexed · h-index 33

Impact in

Biological Psychiatry top 0.5%
- Tryptophan and brain disorders
Behavioral Neuroscience top 0.5%
- Stress Responses and Cortisol

Papers in ⓘ

Endocrinology, Diabetes and Metabolism 39
- Growth Hormone and Insulin-like Growth Factors 31
- Pituitary Gland Disorders and Treatments 9
Cellular and Molecular Neuroscience 27
- Neuroscience and Neuropharmacology Research 13

Co-authors: Abraham Weizman (54 shared papers)Michal Taler (19 shared papers)Biana Shtaif (9 shared papers)Zvi Laron (20 shared papers)Rachel Maayan (8 shared papers)Yechiel Levkovitz (4 shared papers)Daniela Cocchi (15 shared papers)Ella Zeldich (2 shared papers)
Journals: European Neuropsychopharmacology (8 papers)Journal of Molecular Neuroscience (7 papers)European Journal of Endocrinology (5 papers)Life Sciences (5 papers)Neuroendocrinology (4 papers)
Partner nations: Israel Italy United States

In The Last Decade

Irit Gil‐Ad

104 papers receiving 3.0k citations

Peers

Countries citing papers authored by Irit Gil‐Ad

Since Specialization

Citations

This map shows the geographic impact of Irit Gil‐Ad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irit Gil‐Ad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irit Gil‐Ad more than expected).

Fields of papers citing papers by Irit Gil‐Ad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irit Gil‐Ad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irit Gil‐Ad. The network helps show where Irit Gil‐Ad may publish in the future.

Co-authors

The 25 scholars most cited alongside Irit Gil‐Ad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Irit Gil‐Ad Line = papers co-authored together Irit Gil‐Ad links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Elevated levels of serum interleukin-1β in combat-related posttraumatic stress disorder Biological Psychiatry ·Baruch Spivak, Batya Shohat, Roberto Mester, Shlomit Avraham, Irit Gil‐Ad, Avraham Bleich, Avi Valevski, Abraham Weizman	1997	160
2	Differential Induction of Apoptosis by Antidepressants in Glioma and Neuroblastoma Cell Lines: Evidence for p-c-Jun, Cytochrome c, and Caspase-3 Involvement Journal of Molecular Neuroscience ·Yechiel Levkovitz, Irit Gil‐Ad, Ella Zeldich, Michal Dayag, Abraham Weizman	2005	139
3	Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice International Journal of Oncology ·Irit Gil‐Ad	1992	114
4	Elevated circulatory level of GABA_A – antagonistic neurosteroids in patients with combat-related post-traumatic stress disorder Psychological Medicine ·Б. Спивак, Rachel Maayan, Moshe Kotler, Roberto Mester, Irit Gil‐Ad, Biana Shtaif, Abraham Weizman	2000	111
5	The Effects of Fluoxetine Treatment in a Chronic Mild Stress Rat Model on Depression-Related Behavior, Brain Neurotrophins and ERK Expression Journal of Molecular Neuroscience ·Maya First, Irit Gil‐Ad, Michal Taler, Igor Tarasenko, Nurit Novak, Abraham Weizman	2011	109
6	Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression European Neuropsychopharmacology ·Michal Taler, Irit Gil‐Ad, Liat Lomnitski, Inna Korov, Ehud Baharav, Meytal Bar, Amichay Zolokov, Abraham Weizman	2007	96
7	Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: possible implications for Parkinson’s disease Neuroscience Letters ·Daniel Offen, Biana Shtaif, Daphna Hadad, Abraham Weizman, Eldad Melamed, Irit Gil‐Ad	2001	94
8	Characterization of Phenothiazine-Induced Apoptosis in Neuroblastoma and Glioma Cell Lines: Clinical Relevance and Possible Application for Brain-Derived Tumors Journal of Molecular Neuroscience ·Irit Gil‐Ad, Biana Shtaif, Yechiel Levkovitz, Michal Dayag, Ella Zeldich, Abraham Weizman	2004	86
9	Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters Brain Research ·Gitit Attali, Abraham Weizman, Irit Gil‐Ad, Moshe Rehavi	1997	85
10	Olanzapine-Induced Weight Gain in Patients With First-Episode Schizophrenia: A Double-Blind, Placebo-Controlled Study of Fluoxetine Addition American Journal of Psychiatry ·Michael Poyurovsky, Artashes Pashinian, Irit Gil‐Ad, Rachel Maayan, Michael Schneidman, Camil Fuchs, Abraham Weizman	2002	81
11	Haloperidol - induced neurotoxicity - possible implications for tardive dyskinesia Journal of Neural Transmission ·Ronit Galili-Mosberg, Irit Gil‐Ad, Abraham Weizman, E. Melamed, Daniel Offen	2000	68
12	Comparison of Sexual Dysfunction in Male Schizophrenic Patients Maintained on Treatment With Classical Antipsychotics Versus Clozapine The Journal of Clinical Psychiatry ·Dov Aizenberg, Ilan Modai, Aline Teixeira de Landa, Irit Gil‐Ad, Abraham Weizman	2001	67
13	Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth Oncology Reports ·Irit Gil‐Ad, Biana Shtaif, Yechiel Levkovitz, Jardena Nordenberg, Michal Taler, Inna Korov, Abraham Weizman	2006	67
14	Programmed Acute Electrical Stimulation of Ventral Tegmental Area Alleviates Depressive-Like Behavior Neuropsychopharmacology ·Alexander Friedman, Michael Frankel, Yakov Flaumenhaft, Avia Merenlender, Albert Pinhasov, Yuval Feder, Michal Taler, Irit Gil‐Ad, Moshe Abeles, Gal Yadid	2008	66
15	Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study Psychopharmacology ·Michael Poyurovsky, Camil Fuchs, Artashez Pashinian, Aya Levi, Sarit Faragian, Rachel Maayan, Irit Gil‐Ad	2007	63
16	Leu-enkephalin-stimulated growth hormone and prolactin release in the rat: comparison with the effect of morphine Life Sciences ·Daniela Cocchi, A. Santagostino, Irit Gil‐Ad, Sergio Solbes Ferri, Eugenio E. Müller	1977	60
17	Effect of Exposure to Selective Serotonin Reuptake Inhibitors In Utero on Fetal Growth: Potential Role for the IGF-I and HPA Axes Pediatric Research ·Shmuel Davidson, Diana Prokonov, Michal Taler, Rachel Maayan, Daniella Harell, Irit Gil‐Ad, Abraham Weizman	2009	59
18	Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma☆☆☆★ Journal of Allergy and Clinical Immunology ·Benjamin Volovitz, Elvan Tabachnik, Moshe Nussinovitch, Biana Shtaif, Hanna Blau, Irit Gil‐Ad, Abraham Weizman, Itzhak Varsano	1999	58
19	Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-I-binding protein-3, but not GH receptor gene expression in livers of juvenile rats. Endocrinology ·Horacio M. Domené, Kannan Krishnamurthi, R. Eshet, Irit Gil‐Ad, Zvi Laron, I Koch, Bethel Stannard, Fernando Cassorla, Charles T. Roberts, Derek LeRoith	1993	51
20	The effect of famotidine addition on olanzapine-induced weight gain in first-episode schizophrenia patients: a double-blind placebo-controlled pilot study European Neuropsychopharmacology ·Michael Poyurovsky, Vered Tal, Rachel Maayan, Irit Gil‐Ad, Camil Fuchs, Abraham Weizman	2003	50

About Irit Gil‐Ad

Irit Gil‐Ad is a scholar working on Endocrinology, Diabetes and Metabolism, Cellular and Molecular Neuroscience, Molecular Biology, Psychiatry and Mental health and Behavioral Neuroscience, having authored 105 papers that have together received 3.1k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (31 papers), Stress Responses and Cortisol (19 papers), Tryptophan and brain disorders (18 papers), Neuroscience and Neuropharmacology Research (13 papers), Diet and metabolism studies (12 papers), Pituitary Gland Disorders and Treatments (9 papers), Receptor Mechanisms and Signaling (8 papers) and Neurogenesis and neuroplasticity mechanisms (8 papers). The work is most often cited by research in Biological Psychiatry (487 citations), Behavioral Neuroscience (565 citations), Psychiatry and Mental health (657 citations), Developmental Neuroscience (174 citations) and Cellular and Molecular Neuroscience (694 citations). Irit Gil‐Ad has collaborated with scholars based in Israel, Italy and United States. Frequent co-authors include Abraham Weizman, Michal Taler, Biana Shtaif, Zvi Laron, Rachel Maayan, Yechiel Levkovitz, Daniela Cocchi, Ella Zeldich, Eugenio E. Müller and Daniel Offen. Their work appears in journals such as European Neuropsychopharmacology, Journal of Molecular Neuroscience, European Journal of Endocrinology, Life Sciences and Neuroendocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact